Repligen (RGEN) reported Q3 adjusted earnings Tuesday of $0.43 per diluted share, up from $0.23 a year earlier.
Analysts polled by Capital IQ expected $0.33.
Total revenue for the quarter ended Sept. 30 was $154.9 million, up from $141.2 million a year earlier.
Analysts surveyed by Capital IQ expected $153.3 million.
For 2024, the company said it now expects adjusted earnings of $1.50 to $1.58 per diluted share, compared with $1.42 to $1.49 previously. Analysts polled by Capital IQ expect $1.49.
Total reported revenue for the year is now expected to be in the range of $630 million to $639 million, narrowed from the previous outlook of $627 million to $642 million provided by the company in September. Analysts surveyed by Capital IQ expect $629.7 million.
Repligen's shares were up more than 7% in recent premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.